Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 16498-81-0 | MDL No. : | MFCD00085110 |
Formula : | C7H7NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FTEZJSXSARPZHJ-UHFFFAOYSA-N |
M.W : | 153.14 | Pubchem ID : | 708093 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 37.69 |
TPSA : | 59.42 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.75 cm/s |
Log Po/w (iLOGP) : | 0.94 |
Log Po/w (XLOGP3) : | 0.68 |
Log Po/w (WLOGP) : | 0.79 |
Log Po/w (MLOGP) : | -0.96 |
Log Po/w (SILICOS-IT) : | 0.71 |
Consensus Log Po/w : | 0.43 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.49 |
Solubility : | 4.96 mg/ml ; 0.0324 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.5 |
Solubility : | 4.79 mg/ml ; 0.0313 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.51 |
Solubility : | 4.73 mg/ml ; 0.0309 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.49 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302+H312+H332-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | Stage #1: for 6 h; Reflux Stage #2: With sodium hydrogencarbonate In water |
PREPARATION 47 2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-amine [Show Image]a) methyl 2-methoxynicotinate Concentrated aqueous sulphuric acid (0.1 mL) was added to a solution of 2-methoxynicotinic acid (2.00 g, 13.1 mmol) in methanol (20 mL) and the mixture was stirred and heated to reflux. After 6 hours, a saturated aqueous solution of sodium hydrogen carbonate was added and the mixture was extracted with ethyl acetate. The organic layer was dried (MgSO4 and concentrated to give the title compound (1.85 g, 85percent) as a colourless oil. LRMS (m/z): 168 (M+1)+.1H NMR (300 MHz, DMSO-d6) δ ppm 3.81 (s, 3H), 3.92 (s, 3H), 7.11 (dd, 1H), 8.13 (dd, 1H), 8.38(dd, 1H). |
85% | Stage #1: for 6 h; Reflux Stage #2: With sodium hydrogencarbonate In water |
PREPARATION 47 2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-amine a) methyl 2-methoxynicotinate Concentrated aqueous sulphuric acid (0.1 mL) was added to a solution of 2-methoxynicotinic acid (2.00 g, 13.1 mmol) in methanol (20 mL) and the mixture was stirred and heated to reflux. After 6 hours, a saturated aqueous solution of sodium hydrogen carbonate was added and the mixture was extracted with ethyl acetate. The organic layer was dried (MgSO4 and concentrated to give the title compound (1.85 g, 85percent) as a colourless oil. LRMS (m/z): 168 (M+1)+.1H NMR (300 MHz, DMSO-d6) δ ppm 3.81 (s, 3H), 3.92 (s, 3H), 7.11 (dd, 1H), 8.13 (dd, 1H), 8.38(dd, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With bromine In water at 20℃; | To a solution of 2-methoxynicotinic acid (20 g, 130.60 mmol) in H20 (1500 mL), Br2 (20 mL, 375.45 mmol) was added at room temperature. The mixture was stirred at room temperature overnight. The reaction mixture was filtered, washed with water and dried to provide 5-bromo-2-methoxynicotinic acid (25 g, yield: 82percent). 1H- MR (DMSO, 400 MHz) δ 13.33 (br s, 1H), 8.47 (d, J= 2.4 Hz, 1H), 8.21 (d, J= 2.4 Hz, 1H), 3.90 (s, 3H). MS (M+H)+: 232 / 234. |
82% | With bromine In water at 20℃; | Step 1-Synthesis of 5-bromo-2-methoxynicotinic acid To a solution of 2-methoxynicotinic acid (20 g, 130.60 mmol) in H2O (1500 mL), Br2 (20 mL, 375.45 mmol) was added at room temperature. The mixture was stirred at room temperature overnight. The reaction mixture was filtered, washed with water and dried to provide 5-bromo-2-methoxynicotinic acid (25 g, yield: 82percent). 1H-NMR (DMSO, 400 MHz) δ 13.33 (br s, 1H), 8.47 (d, J=2.4 Hz, 1H), 8.21 (d, J=2.4 Hz, 1H), 3.90 (s, 3H). MS (M+H)+: 232/234. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With hydrogenchloride In aqueous sodium hypochlorite | EXAMPLE 1 A 306 mg. (0.002 mole) sample of 2-methoxynicotinic acid (the product of Preparation A) was added in one portion to 20 ml. of well-stirred 5.25percent aqueous sodium hypochlorite solution (Clorox). The resulting mixture (now a solution) was then allowed to stir at room temperature (~20° C.) for a period of approximately 18 hours (i.e., overnight). Upon completion of this step, the reaction mixture was acidified with 10 ml. of 1N hydrochloric acid and the resulting precipitate was subsequently extracted with chloroform. The organic extracts were then combined, dried over anhydrous magnesium sulfate and filtered, and the resulting filtrate was subsequently concentrated in vacuo to afford 195 mg. (52percent) of pure 5-chloro-2-methoxynicotinic acid, m.p. 139°-141° C. (literature m.p. 149°-150° C., according to D. E. Kuhla et al. in U.S. Pat. No. 3,879,403). The pure product was further characterized by means of nuclear magnetic resonance data and mass spectroscopy. |
[ 1060806-77-0 ]
6-Amino-2-methoxynicotinic acid
Similarity: 0.87
[ 1060806-62-3 ]
6-Bromo-2-methoxynicotinic acid
Similarity: 0.87
[ 884494-82-0 ]
5-Fluoro-2-methoxynicotinic acid
Similarity: 0.86
[ 1211581-22-4 ]
2-Methoxy-3-methylisonicotinic acid
Similarity: 0.86
[ 1060806-77-0 ]
6-Amino-2-methoxynicotinic acid
Similarity: 0.87
[ 1060806-62-3 ]
6-Bromo-2-methoxynicotinic acid
Similarity: 0.87
[ 884494-82-0 ]
5-Fluoro-2-methoxynicotinic acid
Similarity: 0.86
[ 1211581-22-4 ]
2-Methoxy-3-methylisonicotinic acid
Similarity: 0.86
[ 54916-66-4 ]
5-Bromo-2-methoxynicotinic acid
Similarity: 0.85
[ 1060806-77-0 ]
6-Amino-2-methoxynicotinic acid
Similarity: 0.87
[ 1060806-62-3 ]
6-Bromo-2-methoxynicotinic acid
Similarity: 0.87
[ 884494-82-0 ]
5-Fluoro-2-methoxynicotinic acid
Similarity: 0.86